Intraperitoneal macrophages and tumor immunity: A review
- 1 October 2000
- journal article
- review article
- Published by Wiley in Journal of Surgical Oncology
- Vol. 75 (2) , 146-154
- https://doi.org/10.1002/1096-9098(200010)75:2<146::aid-jso14>3.0.co;2-1
Abstract
The macrophage (Mϕ) is considered the first line of defense in immune response to foreign invaders. Increasing evidence suggests that Mϕs also play an important role against neoplastic cells. Mϕs exposed to supraphysiologic concentrations of CO2 are suppressed. As surgeons apply newer minimally invasive techniques to oncologic therapies, it is important to evaluate the impact of these techniques on host‐tumor interactions. We review the current understanding of Mϕ biology with specific attention on cytotoxicity in addition to tumor immunity. Although systemic immune function is better preserved after laparoscopy than laparotomy, peritoneal Mϕs show reduced function after CO2 pneumoperitoneum than exposure to air. Mϕs have shown cytotoxicity to syngeneic cancer cells and may play an important role in tumor surveillance. The impairment in Mϕ function after CO2 exposure may have an effect on outcome after oncologic surgery. In our understanding, Mϕs help destroy neoplastic cells. As CO2 impairs Mϕ activity, laparoscopy may significantly alter the host‐tumor interaction. J. Surg. Oncol. 2000:75:146–155.Keywords
This publication has 104 references indexed in Scilit:
- Incidence of port site recurrence after laparoscopic cholecystectomy for preoperatively unsuspected gallbladder carcinomaSurgery, 1998
- Do macrophages kill through apoptosis?Immunology Today, 1996
- Impact of Gas(less) Laparoscopy and Laparotomy on Peritoneal Tumor Growth and Abdominal Wall MetastasesAnnals of Surgery, 1996
- Port-site metastases following diagnostic laparoscopyBritish Journal of Surgery, 1996
- Anandamide inhibits macrophage-mediated killing of tumor necrosis factor-sensitive cellsLife Sciences, 1995
- Port site seeding after laparoscopic ultrasonographic staging of pancreatic carcinomaSurgery, 1995
- Macrophage tumoricidal mechanismsResearch in Immunology, 1993
- Systemic macrophage activation with liposome-entrapped immunomodulators for therapy of cancer metastasisResearch in Immunology, 1992
- Generation of lymphokine-activated killer cells in human ovarian carcinoma ascitic fluid: Identification of transforming growth factor-β as a suppressive factorCancer Immunology, Immunotherapy, 1991
- A differential interaction in vitro of mouse macrophages with normal lymphocytes and malignant lymphoma cellsPublished by Elsevier ,1977